Universe Pharmaceuticals INC (NASDAQ:UPC) Stock Short Interest Report for September

Universe Pharmaceuticals INC (NASDAQ:UPC) was the target of a large decrease in short interest during the month of September. As of September 30th, there was short interest totaling 43,865 shares, a decrease of 42.2% from the September 15th total of 75,844 shares. Based on an average daily volume of 40,506 shares, the short-interest ratio is currently 1.1 days. Currently, 2.0% of the shares of the stock are short sold.

Universe Pharmaceuticals Stock Up 1.3%

Shares of NASDAQ:UPC traded up $0.06 during trading on Thursday, reaching $4.21. The company’s stock had a trading volume of 2,855 shares, compared to its average volume of 707,321. Universe Pharmaceuticals has a 12 month low of $2.00 and a 12 month high of $17.96. The company has a quick ratio of 3.90, a current ratio of 4.05 and a debt-to-equity ratio of 0.04. The firm’s 50 day simple moving average is $4.82 and its two-hundred day simple moving average is $4.07.

Universe Pharmaceuticals (NASDAQ:UPC) last announced its earnings results on Wednesday, July 29th. The company reported ($1.38) EPS for the quarter. The firm had revenue of $4.52 million during the quarter.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on UPC. Wall Street Zen upgraded Universe Pharmaceuticals to a “hold” rating in a research report on Saturday, August 29th. Weiss Ratings upgraded Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 29th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China.

Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products.